Keros Therapeutics, Inc.KROSNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending lower, below historical average.
Left:
||||
Enterprise value to sales ratio
Latest
14.53
↓ 98% below average
Average (6y)
822.90
Historical baseline
Range
High:5656.39
Low:0.00
CAGR
-1.2%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 14.53 | -99.7% |
| 2023 | 5656.39 | - |
| 2022 | 0.00 | -100.0% |
| 2021 | 56.53 | - |
| 2020 | 0.00 | -100.0% |
| 2019 | 17.26 | +10.7% |
| 2018 | 15.59 | - |